Novonesis highlights enzyme-led growth strategy. Integrated biosolutions after Novozymes merger

Novonesis outlines a long-term strategy built on industrial enzymes and microbial solutions after the merger that combined the former Novozymes and Chr. Hansen businesses into a single biosolutions group.

Novonesis (ISIN DK0060336014) has emerged as a major global biosolutions group after the merger that brought together the former Novozymes and Chr. Hansen businesses, creating a broad portfolio of industrial enzymes, microbes, and specialty ingredients for food, agriculture, and a range of industrial applications.

The company positions itself as a science-driven partner to customers across sectors such as food and beverage, household care, bioenergy, and agriculture, aiming to replace or reduce traditional chemical processes with biological alternatives that can improve efficiency and environmental performance over time.

Industrial biosolutions at scale

Novonesis builds on decades of enzyme and microbial technology originally developed under the Novozymes and Chr. Hansen brands, offering ingredients that help manufacturers optimize processes, enhance product quality, and improve yields in their production lines.

Across industries, the group markets biosolutions that can support lower energy use during processing, enable more efficient use of raw materials, and help customers meet tightening regulatory and sustainability requirements in large end-markets.

Food, agriculture, and household applications

In the food and beverage segment, Novonesis supplies cultures, enzymes, and other ingredients that are used in products such as dairy, fermented foods, baked goods, and beverages, where consistent quality and safety are critical for global consumer brands.

In agriculture and animal health, the company offers microbial and enzyme-based solutions that are designed to support crop performance, soil health, and feed efficiency, contributing to more sustainable farming practices over the long term.

Representative product example: industrial enzymes

One representative product family within Novonesis is its range of industrial enzymes, which are used by manufacturers in sectors such as detergents, textiles, food processing, and bioenergy to catalyze specific reactions and improve process efficiency.

Novonesis stock and listing

Novonesis is listed in its home market, where the combined business from the legacy Novozymes and Chr. Hansen entities continues to trade under the new group name, giving investors exposure to a broad portfolio of enzyme and microbial technologies with applications across food, agriculture, and industrial markets.

The company's shares reflect market expectations for demand growth in biosolutions over time as customers seek alternatives to traditional chemical-based processes in response to cost, efficiency, and sustainability pressures.

Novonesis at a glance

• Company: Novonesis
• ISIN: DK0060336014
• Ticker: Not specified
• Exchange: Home-market listing
• Price (as of latest available data): Not specified
• Market cap: Not specified
• Sector / Industry: Specialty chemicals / biosolutions
• Index membership: Not specified
• Next earnings date: Not yet officially scheduled

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.